Effects of IASTM Along With Comprehensive Corrective Exercise Program in Upper Cross Syndrome.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 4, 2024
Trial Information
Current as of November 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how a specific treatment called IASTM (Instrument-Assisted Soft Tissue Mobilization) combined with a corrective exercise program can help people with Upper Cross Syndrome. This condition often causes neck pain and poor posture, and the study aims to see if these treatments can reduce pain, improve neck movement, and enhance overall posture. Importantly, both men and women aged 18 to 40 who have been diagnosed with Upper Cross Syndrome and have had chronic neck pain for more than three months are eligible to participate.
Participants in the study can expect to undergo assessments to measure their pain levels and posture before and after the treatment. The trial is currently recruiting participants, and it is essential to note that individuals with certain conditions, like previous surgeries or specific skin issues, are not eligible to join. This research is significant because it aims to provide insights into how both men and women respond to these treatments, especially since previous studies have focused mainly on men. By including a diverse group, the trial hopes to offer more comprehensive solutions for managing Upper Cross Syndrome.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-40 years.
- • Diagnosed patients with the upper crossed syndrome who have chronic neck
- • pain for more than 3 months.
- • Having neck pain scoring more than 3 on the Numeric Pain Scale were included
- • in this study.
- • Any abnormality in the position and rhythm of the scapula, as measured by the Scapular dyskinesis test, having postural changes such as excessive thoracic kyphosis (≥42°), forward head (≥44°) or round shoulder (≥49°) as measured by Flexicurve and photogrammetry.
- • Both male and female population will be included
- Exclusion Criteria:
- • The subjects with any previous surgery, any type of Infection Hypersensitive skin Diabetes Mellitus type II Having Traumatic Injury Psychological disorder Manual Therapy contraindication like osteoporosis, infection, Disc- Herniation acute Inflammation, burn scars, closed /non-complicated fractures and open wound.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, Federal, Pakistan
Patients applied
Trial Officials
Nadia Ishtiaq, MSOMPT
Principal Investigator
Riphah International university Islamabad
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported